Related Experiment Video
Updated: Feb 11, 2026

Quantification of Hypopigmentation Activity In Vitro
Published on: March 6, 2019
In vitro activity of cefpirome: a new fourth generation cephalosporin
1Department of Microbiology, Sri Venkateswara Institute of Medical Sciences, Tirupati - 517 507, AP, India.
Abstract:
This study was carried out to find the efficacy of Cefpirome in an Indian setting in a tertiary care referral hospital. A total of 516 bacterial isolates from various clinical specimens were tested against cefpirome (Cpo) and compared against the activities of three other cephalosporins, namely cefazolin (Cz), cefuroxime (Cu), and cefotaxime (Ce) as representative of the other three generations. Preliminary testing was done by Kirby Bauer technique. In the gram positive group of organisms (Staphylococcus aureus and coagulase negative staphylococci); 96 strains out of 177 (54.2%) were resistant to Cpo compared to 61.0% for Cz and 72.3% for Cu. In the Enterobacteriaceae group, 66.0% of the isolates were resistant to Cpo compared to 63.2% for Ce; while for Pseudomonas and other non-fermentors, the corresponding figures were 70.7% and 50.0% for Cpo and Ce respectively. The MIC for the strains resistant to Cpo were found to be > 16 mg/L to > 256 mg/L. This study highlights that Cpo did not have superior activity against the organisms isolated in our laboratory. However, since its activity against gram positive and gram negative organisms is comparable to those of Cz and Ce respectively, it may be useful for mixed infections for empirical therapy.
Insights
Cefpirome (Cpo) efficacy was evaluated against 516 bacterial isolates in India. Cefpirome showed comparable activity to other cephalosporins, suggesting potential use in mixed infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Antibiotic resistance is a growing global concern.
- Cephalosporins are widely used antibiotics.
- Evaluating new and existing antibiotics in local settings is crucial.
Purpose of the Study:
- To determine the in vitro efficacy of cefpirome (Cpo) in an Indian tertiary care hospital.
- To compare cefpirome's activity against common bacterial pathogens with other cephalosporins.
- To assess the potential role of cefpirome in empirical therapy for mixed infections.
Main Methods:
- A total of 516 bacterial isolates from various clinical specimens were tested.
- Antibacterial activity was assessed using the Kirby Bauer technique.
- Cefpirome was compared against cefazolin (Cz), cefuroxime (Cu), and cefotaxime (Ce).
Main Results:
- Cefpirome demonstrated resistance rates of 54.2% in Gram-positive organisms and 66.0% in Enterobacteriaceae.
- Resistance rates for cefpirome were comparable to cefazolin for Gram-positives and cefotaxime for Gram-negatives.
- Minimum inhibitory concentrations (MICs) for resistant strains ranged from >16 mg/L to >256 mg/L.
Conclusions:
- Cefpirome did not exhibit superior activity against the studied bacterial isolates.
- Its activity profile suggests potential utility in treating mixed Gram-positive and Gram-negative infections.
- Further studies may be warranted to confirm its role in empirical treatment strategies.
Related Concept Videos
Co-activators and Co-repressors
tRNA Activation
Activation Energy
In-vitro Mutagenesis
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Secondary Active Transport

